Paul R. Hansen - 09 Nov 2021 Form 4 Insider Report for Vyant Bio, Inc.

Role: Director
Signature: /s/ Andrew LaFrence, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 09 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 27 Feb 2023, 16:41:18 UTC
Previous filing: 23 Aug 2021
Next filing: 20 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYNT	Common Stock, $0.0001 par value	Will/Inheritance	$0	+6,783	+4.4%	$0.000000	159,778	09 Nov 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On November 9, 2021, the Reporting Person inherited 6,783 shares of common stock.

Remarks:

The shares reported on this Form 4 have been adjusted to reflect the Issuer's 1-for-5 reverse stock split of its common stock, effective November 2, 2022.